Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Primer Ventures is a venture capital firm based in the United States, specializing in early-stage investments in healthcare and life sciences. They focus on partnering with entrepreneurs to develop innovative products and therapies. The firm targets pre-seed, seed, and Series A stages.
Primer Ventures invests in breakthrough innovations within life science tools and therapeutics. Their investment areas include synthetic biology, genomics, molecular diagnostics, and new therapeutic modalities. Typical investments are made in early-stage companies that are pioneering advancements in these sectors.
Notable portfolio companies include Curio Bioscience, which specializes in single-cell spatial profiling technology and was acquired by Takara. They also back companies developing next-generation digital counting platforms and targeted therapies for drug resistance.
Submit your pitch through their website contact form for consideration.
Yes, Primer Ventures often leads investment rounds, particularly in the pre-seed and seed stages.
The firm is open to follow-on investments in their portfolio companies, especially if they see continued potential for growth and innovation.
Specific details about the size of their current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.